Parenteral versus oral iron therapy for adults and children with chronic kidney disease
Access status:
Open Access
Type
ArticleAbstract
What is this review about? The use of intravenous compared with oral iron supplements in patients with chronic kidney disease (CKD).What is this review about? The use of intravenous compared with oral iron supplements in patients with chronic kidney disease (CKD).
See less
See less
Date
2012-01-01Publisher
WileyLicence
OtherRights statement
This is the peer reviewed version of the following article: [Webster AC, Hodson EH. Parenteral versus oral iron therapy for adults and children with chronic kidney disease. Nephrology 2012, 17 (2012) 774–775. doi: 10.1111/j.1440-1797.2012.01660.x], which has been published in final form at [https://doi.org/10.1111/j.1440-1797.2012.01660.x]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.Faculty/School
Faculty of Medicine and Health, Sydney Medical SchoolCitation
Webster AC, Hodson EH. Parenteral versus oral iron therapy for adults and children with chronic kidney disease. Nephrology 2012, 17 (2012) 774–775. doi: 10.1111/j.1440-1797.2012.01660.xShare